NuCana (NCNA) Enterprise Value (2016 - 2025)
NuCana's (NCNA) quarterly Enterprise Value came in at -$9.0 million in Q4 2025, down 3.64% year-on-year from -$9.3 million in Q4 2024, and up 1.42% quarter-over-quarter from -$9.1 million in Q3 2025.
NuCana (NCNA) Enterprise Value (2016 - 2025) Analysis & Trends
NuCana has disclosed Enterprise Value across 10 years of filings, most recently posting -$9.0 million for Q4 2025.
- Enterprise Value for Q4 2025 came in at -$9.0 million, down 3.64% year-over-year; the trailing twelve-month figure through Dec 2025 was -$9.0 million (down 3.64% YoY), and the FY2025 annual result was -$8.9 million, down 3.15% from the prior year.
- Enterprise Value came in at -$9.0 million for Q4 2025 at NuCana, up from -$9.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$5.0 million in Q1 2025 to a low of -$122.1 million in Q2 2021.
- The 5-year median for Enterprise Value is -$50.1 million (2022), against an average of -$48.5 million.
- Across the five-year window, Enterprise Value slumped 89.24% in 2021 and surged 69.5% in 2025, its largest moves.
- NuCana's Enterprise Value stood at -$81.2 million in 2021, then surged by 39.49% to -$49.2 million in 2022, then jumped by 56.51% to -$21.4 million in 2023, then jumped by 59.48% to -$8.7 million in 2024, then slipped by 3.64% to -$9.0 million in 2025.
- The last three Enterprise Value figures came in at -$9.0 million (Q4 2025), -$9.1 million (Q3 2025), and -$12.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -584.73 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | -8.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.98 Mn |
| Sep 30, 2025 | -9.11 Mn |
| Jun 30, 2025 | -12.48 Mn |
| Mar 31, 2025 | -4.98 Mn |
| Dec 31, 2024 | -8.66 Mn |
| Sep 30, 2024 | -22.38 Mn |
| Jun 30, 2024 | -21.74 Mn |
| Mar 31, 2024 | -16.32 Mn |
| Dec 31, 2023 | -21.38 Mn |
| Sep 30, 2023 | -53.09 Mn |
| Jun 30, 2023 | -52.45 Mn |
| Mar 31, 2023 | -50.94 Mn |
| Dec 31, 2022 | -49.16 Mn |
| Sep 30, 2022 | -59.81 Mn |
| Jun 30, 2022 | -75.89 Mn |
| Mar 31, 2022 | -80.86 Mn |
| Dec 31, 2021 | -81.24 Mn |
| Sep 30, 2021 | -97.92 Mn |
| Jun 30, 2021 | -122.10 Mn |
| Mar 31, 2021 | -120.46 Mn |